BRIACELL THERAPEUTICS CORP. Weighted Average Exercise Price Of Share Options Granted In Share-based Payment Arrangement2019
BRIACELL THERAPEUTICS CORP. (BCTX) reported Weighted Average Exercise Price Of Share Options Granted In Share-based Payment Arrangement2019 of $5.74 per share for the 9-month period ending 2022-04-30, per its 6-K filed 2022-06-13.
Discontinued › Notes › Compensation Related Costs
ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019 · last filed 2022-06-13
| Period end | Weighted Average Exercise Price Of Share Options Granted In Share-based Payment Arrangement2019 6 month | Weighted Average Exercise Price Of Share Options Granted In Share-based Payment Arrangement2019 9 month | Weighted Average Exercise Price Of Share Options Granted In Share-based Payment Arrangement2019 12 month |
|---|---|---|---|
| 2022-04-30 | $5.74 6-K · filed 2022-06-13 | ||
| 2022-01-31 | $5.74 6-K · filed 2022-03-15 | ||
| 2021-07-31 | $4.24 6-K · filed 2022-06-13 | ||
| 2020-07-31 | $50.47 40-F/A · filed 2021-11-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |